Study to Determine the Difference in Reduction of Bioaerosols in a Long-term Care Facility

NCT ID: NCT06506890

Last Updated: 2024-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-05

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a CONTROLLED PROSPECTIVE COHORT study of a long-term care facility. At the start of the study a dedicated section A of the facility ventilation system will have routine HVAC filters of the same dimensions installed, while section B of the same facility ventilation system will have C-POLAR (cationic polymeric coated) HVAC filters installed. There will be continuous Indoor Air Quality monitors (PM 2.5, CO2, VOC, Radon, Temp, and RH) installed at different vent locations throughout the long-term care facility for the duration of the study. Air samples with an Airport MD8 BAMS machine will be taken once a week at various vent locations at the long-term care facility.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a CONTROLLED PROSPECTIVE COHORT study of a long-term care facility. At the start of the study a dedicated section A of the facility ventilation system will have routine HVAC filters of the same dimensions installed, while section B of the same facility ventilation system will have C-POLAR (cationic polymeric coated) HVAC filters installed. There will be continuous Indoor Air Quality monitors (PM 2.5, CO2, VOC, Radon, Temp, and RH) installed at different vent locations throughout Cottonwoods for the duration of the study. Air samples with an Airport MD8 BAMS machine will be taken once a week at various vent locations at the long-term care facility. The aim of this study is to determine the difference in reduction of bioaerosols in a long-term care facility with MERV 13 C-POLAR (cationic polymeric coated) HVAC filters compared to conventional MERV 13 HVAC filters.

Primary Endpoint:

This study aims to determine the reduction of bioaerosols (BAMS) in a facility with a C-POLAR HVAC filter building intervention versus conventional filters.

Secondary Endpoints:

1. Volatile organic compound (VOC)
2. Radon determination
3. Static, passive particulate determination from air
4. Air microbiome analysis
5. Air Quality and Respiratory Staff Survey

Radon gas testing, particulate matter testing (PM2.5) \[fine inhalable particles, with diameters that are generally 2.5 micrometers and smaller\]. Carbon dioxide testing (CO2), VOCs testing \[volatile organic compounds (airborne chemicals)\], relative humidity (RH) testing \[it is a measure of the actual amount of water vapor in the air compared to the total amount of vapor that can exist in the air at its current temperature\], and temperature readings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Air Pollution

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

comparing the difference in reduction of bioaerosols between HVAC filters

comparing the difference in reduction of bioaerosols between HVAC filters.

Group Type OTHER

Use of C-Polar coated HVAC Filter versus conventional HVAC Filter

Intervention Type OTHER

comparing the difference in reduction of bioaerosols between HVAC filters.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of C-Polar coated HVAC Filter versus conventional HVAC Filter

comparing the difference in reduction of bioaerosols between HVAC filters.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

comparing the difference in reduction of bioaerosols between HVAC filters.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Any resident, staff, and any individual who enters the long term care facility will be in a broad sense, involved in this study, as the MERV 13 HVAC filters will be installed within the HVAC system and will not allow anyone to not participate in the study who enters the facility. It is impracticable to carry out this research of comparing two different HVAC filters in an active long term care setting by receiving prior consent from all individuals who may enter, such as vendors or visitors. This research involves no more than minimal risk and may or may not improve air quality or minimize bioaerosols in the facility.

Exclusion Criteria

1\. Does not wish to enter the long-term care facility until completion of study.
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kelowna General Hospital

OTHER_GOV

Sponsor Role collaborator

C-Polar Innovations

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Deanne Taylor, PhD

Role: PRINCIPAL_INVESTIGATOR

Kelowna General Hospital

Michael Mansour, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Harvard Medical School (HMS and HSDM)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kelowna General Hospital

Kelowna, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zachary Walbaum

Role: CONTACT

800-707-8550

Michelle Smith

Role: CONTACT

800-707-8550

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zachary Walbaum, MHE, MPhil

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H23-04137

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.